Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a new version of the study page. This is a metadata update and does not change the study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2, indicating a minor front-end update. No substantive study data or content changes are evident.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision from v3.4.0 to v3.4.1; no changes to study content or site functionality were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.